Standard
Single-inhaler triple therapy fluticasone furoate/umeclidinium/vilanterol versus fluticasone furoate/vilanterol and umeclidinium/vilanterol in patients with COPD : results on cardiovascular safety from the IMPACT trial. / Day, Nicola C.; Kumar, Subramanya; Criner, Gerard; Dransfield, Mark; Halpin, David M. G.; Han, MeiLan K.; Jones, C. Elaine; Kaisermann, Morrys C.; Kilbride, Sally; Lange, Peter; Lomas, David A.; Martin, Neil; Martinez, Fernando J.; Singh, Dave; Wise, Robert; Lipson, David A.
I:
Respiratory research, Bind 21, 2020.
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
Day, NC, Kumar, S, Criner, G, Dransfield, M, Halpin, DMG, Han, MK, Jones, CE, Kaisermann, MC, Kilbride, S
, Lange, P, Lomas, DA, Martin, N, Martinez, FJ, Singh, D, Wise, R & Lipson, DA 2020, '
Single-inhaler triple therapy fluticasone furoate/umeclidinium/vilanterol versus fluticasone furoate/vilanterol and umeclidinium/vilanterol in patients with COPD: results on cardiovascular safety from the IMPACT trial',
Respiratory research, bind 21.
https://doi.org/10.1186/s12931-020-01398-wAPA
Day, N. C., Kumar, S., Criner, G., Dransfield, M., Halpin, D. M. G., Han, M. K., Jones, C. E., Kaisermann, M. C., Kilbride, S.
, Lange, P., Lomas, D. A., Martin, N., Martinez, F. J., Singh, D., Wise, R., & Lipson, D. A. (2020).
Single-inhaler triple therapy fluticasone furoate/umeclidinium/vilanterol versus fluticasone furoate/vilanterol and umeclidinium/vilanterol in patients with COPD: results on cardiovascular safety from the IMPACT trial.
Respiratory research,
21.
https://doi.org/10.1186/s12931-020-01398-wVancouver
Day NC, Kumar S, Criner G, Dransfield M, Halpin DMG, Han MK o.a.
Single-inhaler triple therapy fluticasone furoate/umeclidinium/vilanterol versus fluticasone furoate/vilanterol and umeclidinium/vilanterol in patients with COPD: results on cardiovascular safety from the IMPACT trial.
Respiratory research. 2020;21.
https://doi.org/10.1186/s12931-020-01398-wAuthor
Day, Nicola C. ; Kumar, Subramanya ; Criner, Gerard ; Dransfield, Mark ; Halpin, David M. G. ; Han, MeiLan K. ; Jones, C. Elaine ; Kaisermann, Morrys C. ; Kilbride, Sally ; Lange, Peter ; Lomas, David A. ; Martin, Neil ; Martinez, Fernando J. ; Singh, Dave ; Wise, Robert ; Lipson, David A. / Single-inhaler triple therapy fluticasone furoate/umeclidinium/vilanterol versus fluticasone furoate/vilanterol and umeclidinium/vilanterol in patients with COPD : results on cardiovascular safety from the IMPACT trial. I: Respiratory research. 2020 ; Bind 21.
Bibtex
@article{50a4bc21b36249e9a44371ea901bad9e,
title = "Single-inhaler triple therapy fluticasone furoate/umeclidinium/vilanterol versus fluticasone furoate/vilanterol and umeclidinium/vilanterol in patients with COPD: results on cardiovascular safety from the IMPACT trial",
keywords = "COPD, Triple therapy, LAMA/LABA, ICS/LABA, Cardiovascular safety",
author = "Day, {Nicola C.} and Subramanya Kumar and Gerard Criner and Mark Dransfield and Halpin, {David M. G.} and Han, {MeiLan K.} and Jones, {C. Elaine} and Kaisermann, {Morrys C.} and Sally Kilbride and Peter Lange and Lomas, {David A.} and Neil Martin and Martinez, {Fernando J.} and Dave Singh and Robert Wise and Lipson, {David A.}",
year = "2020",
doi = "10.1186/s12931-020-01398-w",
language = "English",
volume = "21",
journal = "Respiratory Research (Print)",
issn = "1465-9921",
publisher = "BioMed Central Ltd.",
}
RIS
TY - JOUR
T1 - Single-inhaler triple therapy fluticasone furoate/umeclidinium/vilanterol versus fluticasone furoate/vilanterol and umeclidinium/vilanterol in patients with COPD
T2 - results on cardiovascular safety from the IMPACT trial
AU - Day, Nicola C.
AU - Kumar, Subramanya
AU - Criner, Gerard
AU - Dransfield, Mark
AU - Halpin, David M. G.
AU - Han, MeiLan K.
AU - Jones, C. Elaine
AU - Kaisermann, Morrys C.
AU - Kilbride, Sally
AU - Lange, Peter
AU - Lomas, David A.
AU - Martin, Neil
AU - Martinez, Fernando J.
AU - Singh, Dave
AU - Wise, Robert
AU - Lipson, David A.
PY - 2020
Y1 - 2020
KW - COPD
KW - Triple therapy
KW - LAMA/LABA
KW - ICS/LABA
KW - Cardiovascular safety
U2 - 10.1186/s12931-020-01398-w
DO - 10.1186/s12931-020-01398-w
M3 - Journal article
C2 - 32503599
VL - 21
JO - Respiratory Research (Print)
JF - Respiratory Research (Print)
SN - 1465-9921
ER -
